Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Head & Neck 1

Conditions

Venous Thromboembolism 10Pulmonary Embolism 4Venous Thrombosis 3Neoplasms 3Thrombosis 2Multiple Myeloma 2Urinary Bladder Neoplasms 1Thromboprophylaxis 1Thromboembolism 1Thrombocytopenia 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Fibrosis 1Embolism 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

apixaban 2Blood Specimen Collection 2X-Rays 1Technetium Tc 99m Sulfur Colloid 1Saline Solution 1Photons 1Enoxaparin 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thrombosis × apixaban × 1 year × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡